Jci_page_head_homepage_01 Jci_page_head_homepage_02
Masaru Yoshida, Kanna Kobayashi, Timothy T. Kuo, Lynn Bry, Jonathan N. Glickman, Steven M. Claypool, Arthur Kaser, Takashi Nagaishi, Darren E. Higgins, Emiko Mizoguchi, Yoshio Wakatsuki, Derry C. Roopenian, Atsushi Mizoguchi, Wayne I. Lencer, Richard S. Blumberg
Published in Volume 116, Issue 8
J Clin Invest. 2006; 116(8):2142–2151 doi:10.1172/JCI27821
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 2
IgG transport into the lumen of IFABP-mFcRnTg/mβ2mTg/FcRn–/– mice.

(A) Quantitative PCR of cDNA using PCR primers originating in exon 2 in variety of tissues in IFABP-mFcRnTg/mβ2mTg/FcRn–/– (Tg/FcRn–/–) mice. IEC, intestinal epithelial cells. (B) Serum rabbit IgG levels in IFABP-mFcRnTg/mβ2mTg/FcRn–/– (black bars) and littermate control FcRn–/– mice (white bars) at 24, 48, and 120 hours after injection of rabbit IgG. (C) Serum rabbit IgG levels in IFABP-mFcRnTg/mβ2mTg/FcRn–/– mice measured at 12 hours after injection of rabbit IgG (n = 4). (D) Secretory rabbit IgG levels in feces of IFABP-mFcRnTg/mβ2mTg/FcRn–/– mice measured at 12 hours after injection of rabbit IgG as ng per mg of feces (n = 4). *P < 0.05.